vs
Side-by-side financial comparison of Postal Realty Trust, Inc. (PSTL) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $26.0M, roughly 1.1× Postal Realty Trust, Inc.). Postal Realty Trust, Inc. runs the higher net margin — 17.9% vs -147.1%, a 165.0% gap on every dollar of revenue. On growth, Postal Realty Trust, Inc. posted the faster year-over-year revenue change (21.7% vs -67.6%).
Postal Realty Trust, Inc. is a specialized real estate investment trust that acquires, owns, and manages properties primarily leased to the United States Postal Service. Its portfolio includes last-mile postal facilities, sorting centers, and retail post office locations across the U.S., supporting critical mail and package delivery infrastructure.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
PSTL vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.0M | $28.1M |
| Net Profit | $4.6M | $-41.3M |
| Gross Margin | — | — |
| Operating Margin | 39.2% | -147.6% |
| Net Margin | 17.9% | -147.1% |
| Revenue YoY | 21.7% | -67.6% |
| Net Profit YoY | 3.1% | -182.8% |
| EPS (diluted) | $0.16 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.0M | $28.1M | ||
| Q3 25 | $24.3M | $32.5M | ||
| Q2 25 | $23.4M | $15.7M | ||
| Q1 25 | $22.1M | $8.0M | ||
| Q4 24 | $21.4M | $86.6M | ||
| Q3 24 | $19.7M | $2.1M | ||
| Q2 24 | $18.1M | $500.0K | ||
| Q1 24 | $17.3M | $0 |
| Q4 25 | $4.6M | $-41.3M | ||
| Q3 25 | $3.8M | $-51.2M | ||
| Q2 25 | $3.6M | $-44.9M | ||
| Q1 25 | $2.1M | $-33.9M | ||
| Q4 24 | $4.5M | $49.9M | ||
| Q3 24 | $1.1M | $-19.1M | ||
| Q2 24 | $817.0K | $-12.5M | ||
| Q1 24 | $206.0K | $-10.3M |
| Q4 25 | 39.2% | -147.6% | ||
| Q3 25 | 37.6% | -163.7% | ||
| Q2 25 | 37.3% | -302.9% | ||
| Q1 25 | 28.4% | -466.3% | ||
| Q4 24 | 43.2% | 54.5% | ||
| Q3 24 | 24.3% | -1051.6% | ||
| Q2 24 | 22.8% | -3068.0% | ||
| Q1 24 | 17.6% | — |
| Q4 25 | 17.9% | -147.1% | ||
| Q3 25 | 15.7% | -157.4% | ||
| Q2 25 | 15.5% | -285.6% | ||
| Q1 25 | 9.4% | -425.7% | ||
| Q4 24 | 21.1% | 57.7% | ||
| Q3 24 | 5.4% | -925.0% | ||
| Q2 24 | 4.5% | -2503.2% | ||
| Q1 24 | 1.2% | — |
| Q4 25 | $0.16 | $-0.41 | ||
| Q3 25 | $0.13 | $-0.52 | ||
| Q2 25 | $0.12 | $-0.46 | ||
| Q1 25 | $0.06 | $-0.35 | ||
| Q4 24 | $0.17 | $0.52 | ||
| Q3 24 | $0.03 | $-0.20 | ||
| Q2 24 | $0.02 | $-0.13 | ||
| Q1 24 | $-0.01 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $245.0M |
| Total DebtLower is stronger | $361.1M | $96.4M |
| Stockholders' EquityBook value | $285.2M | $114.3M |
| Total Assets | $759.1M | $327.7M |
| Debt / EquityLower = less leverage | 1.27× | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $245.0M | ||
| Q3 25 | $1.9M | $288.2M | ||
| Q2 25 | $1.1M | $240.1M | ||
| Q1 25 | $639.0K | $275.7M | ||
| Q4 24 | $1.8M | $314.0M | ||
| Q3 24 | $970.0K | $204.6M | ||
| Q2 24 | $1.7M | $218.7M | ||
| Q1 24 | $1.9M | $223.6M |
| Q4 25 | $361.1M | $96.4M | ||
| Q3 25 | $347.0M | $96.2M | ||
| Q2 25 | $328.8M | — | ||
| Q1 25 | $306.7M | — | ||
| Q4 24 | $296.7M | $0 | ||
| Q3 24 | $277.0M | — | ||
| Q2 24 | $273.7M | — | ||
| Q1 24 | $247.6M | — |
| Q4 25 | $285.2M | $114.3M | ||
| Q3 25 | $273.9M | $147.7M | ||
| Q2 25 | $250.8M | $192.3M | ||
| Q1 25 | $245.5M | $229.0M | ||
| Q4 24 | $251.3M | $256.8M | ||
| Q3 24 | $245.6M | $201.0M | ||
| Q2 24 | $245.5M | $215.2M | ||
| Q1 24 | $248.1M | $223.9M |
| Q4 25 | $759.1M | $327.7M | ||
| Q3 25 | $735.2M | $372.8M | ||
| Q2 25 | $689.8M | $313.5M | ||
| Q1 25 | $654.0M | $327.3M | ||
| Q4 24 | $646.8M | $351.2M | ||
| Q3 24 | $615.1M | $217.6M | ||
| Q2 24 | $608.2M | $222.0M | ||
| Q1 24 | $584.1M | $227.6M |
| Q4 25 | 1.27× | 0.84× | ||
| Q3 25 | 1.27× | 0.65× | ||
| Q2 25 | 1.31× | — | ||
| Q1 25 | 1.25× | — | ||
| Q4 24 | 1.18× | 0.00× | ||
| Q3 24 | 1.13× | — | ||
| Q2 24 | 1.11× | — | ||
| Q1 24 | 1.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $44.5M | $-43.5M |
| Free Cash FlowOCF − Capex | $37.6M | — |
| FCF MarginFCF / Revenue | 144.5% | — |
| Capex IntensityCapex / Revenue | 26.7% | 0.0% |
| Cash ConversionOCF / Net Profit | 9.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $44.5M | $-43.5M | ||
| Q3 25 | $10.9M | $-47.0M | ||
| Q2 25 | $11.4M | $-39.6M | ||
| Q1 25 | $10.8M | $-40.7M | ||
| Q4 24 | $33.5M | $42.0M | ||
| Q3 24 | $8.0M | $-14.5M | ||
| Q2 24 | $9.9M | $-7.3M | ||
| Q1 24 | $6.4M | $-6.7M |
| Q4 25 | $37.6M | — | ||
| Q3 25 | $8.8M | $-47.2M | ||
| Q2 25 | $9.1M | $-39.6M | ||
| Q1 25 | $10.2M | $-40.8M | ||
| Q4 24 | $30.7M | $41.7M | ||
| Q3 24 | $7.4M | $-14.6M | ||
| Q2 24 | $8.9M | $-7.3M | ||
| Q1 24 | $5.8M | $-6.8M |
| Q4 25 | 144.5% | — | ||
| Q3 25 | 36.1% | -145.4% | ||
| Q2 25 | 38.8% | -252.2% | ||
| Q1 25 | 45.9% | -512.1% | ||
| Q4 24 | 143.8% | 48.2% | ||
| Q3 24 | 37.6% | -706.3% | ||
| Q2 24 | 49.4% | -1463.4% | ||
| Q1 24 | 33.6% | — |
| Q4 25 | 26.7% | 0.0% | ||
| Q3 25 | 8.9% | 0.6% | ||
| Q2 25 | 10.1% | 0.3% | ||
| Q1 25 | 3.0% | 1.1% | ||
| Q4 24 | 13.0% | 0.3% | ||
| Q3 24 | 3.2% | 6.8% | ||
| Q2 24 | 5.4% | 7.6% | ||
| Q1 24 | 3.5% | — |
| Q4 25 | 9.59× | — | ||
| Q3 25 | 2.87× | — | ||
| Q2 25 | 3.16× | — | ||
| Q1 25 | 5.20× | — | ||
| Q4 24 | 7.44× | 0.84× | ||
| Q3 24 | 7.48× | — | ||
| Q2 24 | 12.10× | — | ||
| Q1 24 | 31.07× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PSTL
Segment breakdown not available.
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
